Holen Sie sich die Stockscreener-App
6.25
2.97%
0.18
Finanzdaten der Cartesian Therapeutics Inc-Aktie (RNAC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
109.51%
0.947
|
0.452 | 0.298 | 1.10 | -0.759 |
Operating Expenses
|
269.86%
79.59
|
21.52 | 22.11 | 22.99 | 25.97 |
| Benefits Costs and Expenses |
142.29
|
- | - | - | 116.05 |
| Costs And Expenses |
251.69%
75.68
|
21.52 | 22.11 | 22.99 | 59.21 |
| Operating Income/Loss |
273.30%
-78.64
|
-21.07 | -21.81 | -21.89 | -26.73 |
| Income/Loss From Continuing Operations Before Tax |
31,371%
-141.34
|
0.452 | 15.89 | -17.71 | -116.81 |
| Income/Loss From Continuing Operations After Tax |
157.86%
-92.58
|
-35.90 | 15.89 | -17.71 | -10.25 |
|
Net Income/Loss
|
157.86%
-92.58
|
-35.90 | 15.89 | -17.71 | -10.25 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.96%
0.011
|
26.00 | 25.98 | 25.90 | 2.7152 |
| Diluted Average Shares |
99.96%
0.011
|
26.00 | 26.45 | 25.90 | 2.7963 |
| Basic Earnings Per Share |
158.70%
-3.57
|
-1.38 | 0.51 | -0.68 | 0.13 |
| Diluted Earnings Per Share |
158.70%
-3.57
|
-1.38 | 0.50 | -0.68 | 0.12 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):